SLAFVDVLN
SLAFVDVLN, a molecular peptide, is a BACE-1 inhibitor with a Ki value of 94 nM. SLAFVDVLN can reduce Aβ42 production[1].
Product Specifications
UNSPSC
12352209
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Field of Research
Metabolic Disease; Neurological Disease
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N
Molecular Formula
C45H72N10O14
Molecular Weight
977.11
References & Citations
[1]Boldin R, et al. Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1. Front Pharmacol. 2023 Jun 16;14:1184006.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6325068-01 0.1 mL
NFKBIA, Phosphorylated (Ser32) (NFKBIA, IKBA, MAD3, NFKBI, NF-kappa-B inhibitor alpha, I-kappa-B-alpha, Major histocompatibility complex enhancer-binding protein MAD3) (MaxLight 750)
Ask
View Details 
MBS6325068-02 5x 0.1 mL
NFKBIA, Phosphorylated (Ser32) (NFKBIA, IKBA, MAD3, NFKBI, NF-kappa-B inhibitor alpha, I-kappa-B-alpha, Major histocompatibility complex enhancer-binding protein MAD3) (MaxLight 750)
Ask
View Details 